Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Supermax BhdXKLS:7106 -1.89%50 Forward PE Ratio is 56.88 as of Aug. 04, 2026. GuruFocus rates XKLS:7106 with a GF Score™ of 50/100 and a GF Value™ of RM0.70 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 391 Medical Devices & Instruments companies, Supermax Bhd ranks worse than 86.45% on this metric.
Supermax Bhd's Forward PE Ratio for today is 56.88.
Supermax Bhd (XKLS:7106) Forward PE Ratio Explanation
The Forward PE Ratio of a company is often used to compare current earnings to estimated future earnings, as well as gaining a clearer picture of what earnings will look like without charges and other accounting adjustments. If earnings are expected to grow in the future, the Forward PE Ratio will be lower than the current PE Ratio. This measure is also used to compare one company to another with a forward-looking focus.
Trailing PE Ratio relies on what is already done. It uses the current share price and divides by the total EPS (Basic) over the past 12 months. PE Ratio can be affected by Non Operating Income such as the sale of part of businesses. This may increase for the current year or quarter dramatically. But it cannot be repeated over and over. Therefore PE Ratio without NRI is a more accurate indication of valuation than PE Ratio .
Supermax Bhd Forward PE Ratio Related Terms
Supermax Bhd Forward PE Ratio Historical Data
* Premium members only.
The historical data trend for Supermax Bhd's Forward PE Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Supermax Bhd Forward PE Ratio Chart
Supermax Bhd Annual Data
Trend
2021-06
2022-06
2023-06
2024-06
2025-06
Forward PE Ratio
3.89
12.72
55.25
47.39
195.00
Supermax Bhd Quarterly Data
2021-06
2021-09
2021-12
2022-03
2022-06
2022-09
2022-12
2023-03
2023-06
2023-09
2023-12
2024-03
2024-06
2024-09
2024-12
2025-03
2025-06
Forward PE Ratio
3.89
3.05
3.57
17.45
12.72
13.23
26.39
63.69
55.25
59.17
67.11
44.25
47.39
68.97
106.67
178.75
195.00
XKLS:7106 vs ISRG, BDX, MDLN: Forward PE Ratio Comparison
For the Medical Instruments & Supplies subindustry, Supermax Bhd's Forward PE Ratio, along with its competitors' market caps and Forward PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Supermax Bhd Forward PE Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Supermax Bhd's Forward PE Ratio distribution charts can be found below:
* The bar in red indicates where Supermax Bhd's Forward PE Ratio falls into.
It's a measure of the price-to-earnings ratio (PE Ratio) using forecasted earnings for the calculation. While the earnings used are just an estimate and are not as reliable as current earnings data, there is still benefit in estimated P/E analysis. The forecasted earnings used in the formula can either be for the next 12 months or for the next full-year fiscal period.
Supermax Bhd (XKLS:7106) has a Forward PE Ratio of 56.88 as of Aug. 04, 2026. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Supermax Bhd and its competitors. According to the industry distribution chart, Supermax Bhd ranks #338 out of 391 companies in the Medical Devices & Instruments industry, placing it in the top 86.4%.
Is Supermax Bhd's Forward PE Ratio too high?
Supermax Bhd's current Forward PE Ratio is 56.88. The Medical Devices & Instruments industry median Forward PE Ratio is 19.42. Supermax Bhd's value of 56.88 is 192.9% above this industry median. Based on the distribution chart, Supermax Bhd ranks #338 out of 391 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Supermax Bhd has a GF Score™ of 50/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Supermax Bhd's Forward PE Ratio compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Supermax Bhd ranks #338 out of 391 companies for Forward PE Ratio. This places Supermax Bhd in the lower half of its industry. The industry median Forward PE Ratio is 19.42. Supermax Bhd's value of 56.88 is 192.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward PE Ratio for a Medical Devices & Instruments company?
The median Forward PE Ratio among Medical Devices & Instruments companies is 19.42, based on 391 companies in the industry. Companies in the top quartile (top 25%) have a Forward PE Ratio significantly above this median, while those in the bottom quartile fall well below. However, Forward PE Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Supermax Bhd's current Forward PE Ratio of 56.88 is 192.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward PE Ratio mean?
A high Forward PE Ratio can signal that a stock is expensive relative to its fundamentals. Forward P/E ratio is the share price dividend by the expected per-share earnings in the next 12 months. View historical data on Supermax Bhd and its competitors. For the Medical Devices & Instruments industry, the median Forward PE Ratio is 19.42 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Supermax Bhd's current Forward PE Ratio is 56.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Supermax Bhd stock overvalued right now?
Based on GuruFocus' analysis, Supermax Bhd (XKLS:7106) is currently considered Possible Value Trap. The stock's GF Value™ is RM0.70, compared to a current price of RM0.26 — trading 62.9% below its estimated fair value. The current Forward PE Ratio is 56.88 and 192.9% above the Medical Devices & Instruments industry median of 19.42. Supermax Bhd's overall GF Score™ is 50/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward PE Ratio calculated?
Forward PE Ratio is calculated from a company's financial statements. For Supermax Bhd (XKLS:7106), the current Forward PE Ratio is 56.88 as of Aug. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Supermax Bhd (XKLS:7106) Overvalued in 2026?
Based on GuruFocus' analysis, Supermax Bhd stock appears to be undervalued.
The current stock price of RM0.26 is trading 62.9% below its estimated GF Value™ of RM0.70.
GuruFocus considers Supermax Bhd to be Possible Value Trap.
Key valuation signals for XKLS:7106:
Forward PE Ratio: 56.88
GF Value™: RM0.70 vs. price of RM0.26 (62.9% below fair value)
Industry Position: 192.9% above the Medical Devices & Instruments median (#338 of 391)
No single metric tells the full story. See the XKLS:7106 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Supermax Corp Bhd is an investment holding company. Along with its subsidiaries, the company operates as an international manufacturer, distributor, and marketer of high-quality medical gloves and contact lenses. It offers various types of latex gloves, which are exported to numerous countries. The company is organized into the following reportable operating segments: manufacturing of gloves, which generates the majority of revenue; investment holding; trading of gloves; and others. Geographically, it derives the majority of its revenue from Europe, with the remainder coming from Africa, Asia and Oceania, and North, Central, and South America.
50GF Score
Get the complete analysis for XKLS:7106
Forward PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XKLS:7106 has been successfully added to your 
